Cancer research

Texas has emerged as a major player in the biotech industry, with several cities in the state becoming hubs for...

The Food and Drug Administration (FDA) has recently cleared the Phase 1B Investigational New Drug (IND) application for TCB-008, a...

Weekly Summary: Clonal Expansion, Golden Retriever Cancer, and FTC’s Actions Against Deceptive Genetics Firm In this week’s summary, we will...

German pharmaceutical company Boehringer Ingelheim has announced its plans to acquire T3, a bacterial oncology company, in a move that...

Title: A New Study Reveals How Cancer Cells Exploit Cellular Mechanisms for Survival Introduction: Cancer, a complex and devastating disease,...

Title: A Study on SPACEL: Understanding Spatial Transcriptome Architectures Using Deep Learning Introduction: In recent years, advancements in genomics and...

The Role of Apoptotic Dysregulation in Stem Cell Competition and Tissue Regeneration – Insights from Nature Communications Stem cells are...

The Food and Drug Administration (FDA) has recently approved Truqap Plus Faslodex as a new treatment option for patients with...

Alkermes, a leading biopharmaceutical company, has recently announced the establishment of a new subsidiary called Mural Pharmaceuticals. This new company...

ESMO 2023: A Comprehensive Overview of ADCs in Catalyst Clinical Research The European Society for Medical Oncology (ESMO) is one...

Flatiron Health and Penn Medicine Announce New Partnership Flatiron Health, a leading healthcare technology company, and Penn Medicine, one of...

Flatiron Health and Penn Medicine have recently announced a groundbreaking partnership aimed at advancing cancer research and improving patient care....

The third quarter of 2023 has witnessed some remarkable funding rounds in the United States, with several startups securing substantial...

Characterization of New Pulmonary Adenocarcinoma Cell Lines Derived from a Dog: A Phenotypic and Molecular Analysis Pulmonary adenocarcinoma is a...

American Airlines customers have once again demonstrated their generosity and commitment to making a difference in the fight against cancer....